F.J. Quinn

The long-recommended practice of shared data and plans between biopharma companies and their contract manufacturing organizations (CMOs) is beginning to take hold

Structured product labeling--along with more formalized methods of tracking changes--seek to improve patient safety

Although overshadowed by oral solids, oral liquids provide important benefits for pediatric, geriatric and specialized therapies

Parenteral (injectable) drugs gain user acceptance even as biotech brings more of them onto the market

Sustainability initiatives add to the complexity of managing reverse logistics for life sciences products